Skip to main content
. 2014 Dec 5;41(2):139–147. doi: 10.1007/s13318-014-0242-5

Fig. 3.

Fig. 3

Percentage changes (mean ± SD) from baseline in creatinine-corrected urinary CTX after administration of 100 mg oral ibandronate and 1.0 mg i.v. ibandronate